Arteriosclerosis, Vol 9, 538-549, Copyright © 1989 by American Heart Association

ARTICLES

Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages

HF Hoff, J O'Neil, GM Chisolm 3d, TB Cole, O Quehenberger, H Esterbauer and G Jurgens
Department of Atherosclerosis Research, Cleveland Clinic Foundation, OH 44106.

There is indirect evidence that the oxidation of low density lipoprotein (LDL) may be involved in the development of atherosclerosis. Modification of LDL by oxidation may lead to its unregulated uptake by intimal macrophages to form foam cells. Because of the complexity of events occurring during LDL oxidation, we have tested whether LDL modified directly with 4-hydroxynonenal (HNE), a major propagation product formed during lipid peroxidation and known to be present in oxidized LDL, could bring about lipid loading of macrophages. Modification was accomplished by incubating LDL with various concentrations of HNE up to 7.5 mM. When LDL was derivatized with lower concentrations of HNE, concentration-dependent increases were observed in the covalent binding of HNE to apolipoprotein B (apo B), the blockage of the epsilon-amino groups on lysine residues of apo B, and the relative electrophoretic mobility of LDL. Decreases were observed in degradation of the modified LDL by the J774 cell line, mouse peritoneal macrophages, and smooth muscle cells. Modification of LDL by incubation with the higher concentrations of HNE resulted in LDL aggregation. This modification was associated with marked increases in the macrophage degradation of LDL. Degradation of aggregated HNE- modified LDL increased linearly with incubation time, leading to lipid loading of these cells as observed by oil red O staining and cholesterol accumulation. Uptake appeared to occur by phagocytosis, since cytochalasin D, an inhibitor of phagocytosis, quantitatively inhibited uptake and degradation of labeled HNE LDL. Uptake did not appear to be mediated by either the LDL receptor or the scavenger receptor, since competition with excess amounts of LDL or acetyl LDL failed to inhibit degradation of labeled, aggregated HNE LDL. Saturation of degradation of HNE LDL by macrophages could be attributed, in part, to steric hindrance, since both excess HNE LDL and other particulate ligands could inhibit this degradation. These studies suggest that interaction of LDL with HNE formed during lipid peroxidation could be responsible for structural modifications leading to unregulated uptake of the lipoprotein by tissue macrophages. This could partially explain lipid loading or foam cell formation in atherosclerosis.

This article has been cited by other articles:

				I. M. Qahwash, A. Boire, J. Lanning, T. Krausz, P. Pytel, and S. C. Meredith Site-specific Effects of Peptide Lipidation on -Amyloid Aggregation and Cytotoxicity J. Biol. Chem., December 21, 2007; 282(51): 36987 - 36997. [Abstract] [Full Text] [PDF]

				C. H. Kim, Y. Zou, D. H. Kim, N. D. Kim, B. P. Yu, and H. Y. Chung Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging. J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 332 - 338. [Abstract] [Full Text] [PDF]

				E. P. Simpson, Y. K. Henry, J. S. Henkel, R. G. Smith, and S. H. Appel Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden Neurology, May 25, 2004; 62(10): 1758 - 1765. [Abstract] [Full Text] [PDF]

				H. F. Hoff, J. O'Neil, Z. Wu, G. Hoppe, and R. L. Salomon Phospholipid Hydroxyalkenals: Biological and Chemical Properties of Specific Oxidized Lipids Present in Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 275 - 282. [Abstract] [Full Text] [PDF]

				W. Huang, I. Ishii, W.-Y. Zhang, M. Sonobe, and H. S. Kruth PMA activation of macrophages alters macrophage metabolism of aggregated LDL J. Lipid Res., August 1, 2002; 43(8): 1275 - 1282. [Abstract] [Full Text] [PDF]

				S. Marathe, G. Kuriakose, K. J. Williams, and I. Tabas Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2648 - 2658. [Abstract] [Full Text] [PDF]

				S. C. Whitman, S. L. Hazen, D. B. Miller, R. A. Hegele, J. W. Heinecke, and M. W. Huff Modification of Type III VLDL, Their Remnants, and VLDL From ApoE-Knockout Mice by p-Hydroxyphenylacetaldehyde, a Product of Myeloperoxidase Activity, Causes Marked Cholesteryl Ester Accumulation in Macrophages Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1238 - 1249. [Abstract] [Full Text] [PDF]

				P. Holvoet, J. Vanhaecke, S. Janssens, F. Van de Werf, and D. Collen Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease Circulation, October 13, 1998; 98(15): 1487 - 1494. [Abstract] [Full Text] [PDF]

				W.-Y. Zhang, P. M. Gaynor, and H. S. Kruth Aggregated Low Density Lipoprotein Induces and Enters Surface-connected Compartments of Human Monocyte-Macrophages. UPTAKE OCCURS INDEPENDENTLY OF THE LOW DENSITY LIPOPROTEIN RECEPTOR J. Biol. Chem., December 12, 1997; 272(50): 31700 - 31706. [Abstract] [Full Text] [PDF]

				A. Hammer, G. Kager, G. Dohr, H. Rabl, I. Ghassempur, and G. Jurgens Generation, Characterization, and Histochemical Application of Monoclonal Antibodies Selectively Recognizing Oxidatively Modified ApoB-Containing Serum Lipoproteins Arterioscler Thromb Vasc Biol, May 1, 1995; 15(5): 704 - 713. [Abstract] [Full Text]

				E. Malle, A. Ibovnik, H. J. Leis, G. M. Kostner, P. F. J. Verhallen, and W. Sattler Lysine Modification of LDL or Lipoprotein(a) by 4-Hydroxynonenal or Malondialdehyde Decreases Platelet Serotonin Secretion Without Affecting Platelet Aggregability and Eicosanoid Formation Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 377 - 384. [Abstract] [Full Text]

				R. M. Hoffman and H. S. Garewal Antioxidants and the Prevention of Coronary Heart Disease Arch Intern Med, February 13, 1995; 155(3): 241 - 246. [Abstract] [PDF]